Alto Neuroscience, Inc.
ANRO · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $168 | $83 | $48 | $26 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $1 | $2 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $3 | $0 | $0 |
| Total Curr. Assets | $169 | $85 | $49 | $28 |
| Property Plant & Equip (Net) | $8 | $1 | $2 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $1 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $8 | $1 | $2 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $178 | $87 | $51 | $29 |
| Liabilities | – | – | – | – |
| Payables | $2 | $1 | $2 | $1 |
| Short-Term Debt | $1 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $8 | $4 | $4 | $1 |
| Total Curr. Liab. | $10 | $6 | $6 | $2 |
| LT Debt | $16 | $10 | $82 | $38 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $143 | $2 | $1 |
| Total NC Liab. | $16 | $153 | $84 | $39 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $5 | $0 | $0 | $0 |
| Total Liabilities | $26 | $158 | $89 | $41 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$138 | -$77 | -$41 | -$13 |
| AOCI | -$0 | -$0 | -$0 | -$0 |
| Other Equity | $290 | $5 | $2 | $0 |
| Total Equity | $151 | -$72 | -$38 | -$12 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $178 | $87 | $51 | $29 |
| Net Debt | -$151 | -$73 | $34 | $12 |